About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Lymphoma Clinical Trials | 6,621 Studies Recruiting

Clinical TrialsLymphoma

Lymphoma Clinical Trials

Browse 6,621 clinical trials for lymphoma. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 6001-6020 of 6,621 trials

CompletedEfficacy Study of T Cell Depleted Allogeneic Non-myeloablative Stem Cell TransplantThe central hypothesis of this study is that use of a less toxic chemotherapy preparative regimen for allogeneic hematopoietic stem cell transplantation in combination with T cell…NCT00597714·Durham, North Carolina TerminatedR-CHOP-B Bevacizumab for Diffuse Large B Cell LymphomaThis study evaluates the use of the standard treatment R-CHOP plus the anti-VEGF drug, bevacizumab and whether this treatment is feasible in patients with stage II, III and IV…NCT00788606·Sutton, Surrey and 1 other Active not recruitingAcalabrutinib-Lenalidomide-Rituximab in Patients With Untreated MCLThis is a multi-arm phase 2 study to evaluate the preliminary evidence of efficacy and safety of the combination of acalabrutinib, lenalidomide and rituximab (ALR) and…NCT03863184·New York, New York

Related Searches

hodgkintrials non-hodgkintrials

Data from ClinicalTrials.govTerms

CompletedSafety & Effectiveness of TENS Weight Management Compared to a ShamThis is a multicenter, randomized, blinded, parallel group, controlled study intended to evaluate the safety and effectiveness of treating overweight and Class 1 obese patients…NCT05675384·Scottsdale, Arizona and 5 others

UnknownSerum and Tissue Level of Interleukin-15 (IL-15) and IL-15 Receptor Alpha (IL-15Rα) in Mycosis FungoidesEstimation of serum and tissue level of IL-15 and IL-15 R α in mycosis fungoides prior to after treatment.NCT05526638·Cairo

CompletedAprepitant's Effect on Drug Metabolism in Multi-Day Combination (CHOP/R-CHOP) Chemotherapy Regimen in Lymphoma PatientsThe goal of this clinical research study is to learn the effect of combining aprepitant with CHOP or R-CHOP in patients with Non-Hodgkin's Lymphoma (NHL) that is either newly…NCT00651755·Houston, Texas

CompletedMothers Understand And Can do it - Mid Upper Arm Circumference Screening for Malnutrition Performed by MothersPRIMARY OBJECTIVE : To determine whether mothers, given minimal group training, are capable of using a MUAC (mid-upper arm circumference) bracelet to screen their children for…NCT01790815·Mirriah, Mirriah

RecruitingFertility Sparing Therapy for Patients With Stage IA G2 Endometrial CancerEndometrial cancer (EC) is a prevalent gynecological cancer with an escalating global incidence and a decreasing age of onset.NCT06468215·Beijing, Beijing Municipality

Enrolling by invitationMenstrual Management Using a Mobile Application in Adolescent Girls With Mild Intellectual DisabilitiesIn the study conducted to determine the effectiveness of menstruation management training given with a mobile application (Bağımsız Yapabilirim) in female adolescents with mild…NCT07016932·Konya, Selçuklu

CompletedRomidepsin, Ifosfamide, Carboplatin, and Etoposide in Treating Participants With Relapsed or Refractory Peripheral T-Cell LymphomaThis phase I trial studies the best dose and side effects of romidepsin when given in combination with ifosfamide, carboplatin, and etoposide in treating participants with…NCT01590732·Houston, Texas

RecruitingA Phase 2 Trial of GlOfitamab anD pIrtobrutinib in Mantle Cell Lymphoma Patients With Prior BTK Inhibitor Exposure.The goal of this clinical trial is to evaluate the safety and response of combining Pirtobrutinib and Glofitimab in patients with relapsed MCL.NCT05833763·Parkville, Victoria and 1 other

Unknowna Clinical Research of CD19 and CD22 Targeted Prime CAR-T Cell in Relapsed/Refractory B Cell LymphomaThis is a single arm study to evaluate the efficacy and safety of CD19 and CD22 targeted prime CAR-T cells therapy for patients with relapsed/refractory B Cell LymphomaNCT04782193·Kunming, Yunnnan

UnknownBiomarker Guided Treatment in DLBCLThis study is to investigate the strategy of biomarker guided treatment in diffuse large B cell lymphomaNCT04025593·Shanghai, Shanghai Municipality

UnknownClinical Trial of SL1904B CAR-T Cells for Relapsed or Refractory Non-Hodgkin LymphomaThis is a study of patients with relapsed or refractory non-Hodgkin's lymphoma.NCT04447547·Beijing, Yizhuang and 1 other

CompletedSafety and Efficacy of MMX Mesalamine/Mesalazine in Pediatric Subjects With Mild to Moderate Ulcerative ColitisTo assess clinical response to MMX mesalamine/mesalazine between a low and high dose in children and adolescents aged 5-17 years with mild to moderate Ulcerative Colitis (UC) or…NCT02093663·Baltimore, Maryland and 32 others

CompletedSequential Intranodal Immunotherapy (SIIT) Combined With Anti-PD1 (Pembrolizumab) in Follicular LymphomaFollicular lymphoma (FL) is the most common subtype of indolent non-Hodgkin's lymphoma and is often diagnosed in advanced incurable stage.NCT02677155·Oslo

TerminatedPTK787 in Refractory or Relapsed Diffuse Large Cell LymphomaThis is a phase II open label study to assess the efficacy and safety of PTK787/ZK222584 in adults with relapsed or refractory diffuse large cell lymphoma (DLCL).NCT00511043·Chapel Hill, North Carolina and 2 others

UnknownCyBeR Association in Relapsed/Refractory DLBCLForty percent of patients with diffuse large B cell lymphoma (DLBCL) have primary refractory or relapsed disease (R/R).NCT02758925

RecruitingLong-term Ovarian Fertility in Patients Treated for Lymphoma.This is an observational, single-center, longitudinal cohort study.NCT05616325·Lille

UnknownHuman Mesenchymal Stem Cells For Moderate and Severe Bronchopulmonary DysplasiaThis study is an open-label, single-center, dose escalation study to evaluate of safety and efficacy of human umbilical cord -derived mesenchymal stem cells (hUC-MSCs) in children…NCT03601416·Chongqing, Chongqing Municipality

PreviousPage 301 of 332Next